Valeant Pharmaceuticals (VRX) needs a ‘fix it” third party to come in and stop the bleeding. Moreover, the current management team is stuck in ‘deer in headlights mode’, and needs to start taking proactive steps to resolve the overhang that is weighing down investor confidence on the street.
User rating: 0.00% ( 0 
The Complete List Of Wilshire 5000 Stocks
Future Market Returns = Dividend Yield + Earnings Growth +/- Change In P/E Ratio
USD/JPY Making A Bullish N Pattern Through Chuvashov Fork
Ebay Rises As Morgan Stanley Double Upgrades On Payments Shakeup
The Pension Crisis Gets A Catchy Name: “Silver Tsunami”
